학술논문

A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of age
Document Type
Article
Source
In: Vaccine. (Vaccine, 7 December 2023, 41(50):7548-7559)
Subject
Language
English
ISSN
18732518
0264410X